Cambridge, United States
Aiomic, established in 2020, is a U.S.-based startup revolutionizing clinical data processes in hospitals through artificial intelligence. The company’s platform, Aiomic360™, delivers an integrated solution for case selection, data abstraction, and reporting, all while maintaining robust security by operating behind hospital firewalls.
The solution targets accreditation, compliance, and quality registry needs, offering a competitive edge with its explainable AI capabilities. With a strong emphasis on efficiency and quality, Aiomic stands out in the health tech industry by streamlining processes that are traditionally labor-intensive.
In its recent funding round, Aiomic secured a $1.40M Convertible Note investment from the BioInnovation Institute on 01 March 2023. This investment signals robust confidence from stakeholders and positions Aiomic for further growth and innovation in healthcare AI solutions.
